What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Radiology
His primary scientific interests are in Nuclear medicine, Positron emission tomography, Radiology, Internal medicine and Blood flow.
His study on Pet imaging is often connected to Comparison study as part of broader study in Nuclear medicine.
The concepts of his Positron emission tomography study are interwoven with issues in Pathology, Histopathology and Cancer.
His research integrates issues of Lung cancer and Breast cancer in his study of Radiology.
His work deals with themes such as Endocrinology, Oncology, Isoflurane, Cardiology and Xylazine, which intersect with Internal medicine.
His Blood flow study integrates concerns from other disciplines, such as Hemodynamics, Anesthesia, Circulatory system and Vasodilation.
His most cited work include:
- A Tabulated Summary of the FDG PET Literature (804 citations)
- Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (730 citations)
- Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer (528 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Nuclear medicine, Positron emission tomography, Radiology, PET-CT and Internal medicine.
His Nuclear medicine research incorporates themes from Tomography, Biodistribution and Histopathology.
His Positron emission tomography research includes elements of Cancer, Magnetic resonance imaging, Molecular imaging and Pathology.
Johannes Czernin has researched Radiology in several fields, including Neoadjuvant therapy, Breast cancer, Lymph node and Stage.
His work in PET-CT tackles topics such as Prostate cancer which are related to areas like Cancer research and Radionuclide therapy.
In the field of Internal medicine, his study on Clinical trial overlaps with subjects such as In patient.
He most often published in these fields:
- Nuclear medicine (29.75%)
- Positron emission tomography (25.95%)
- Radiology (23.27%)
What were the highlights of his more recent work (between 2017-2021)?
- Prostate cancer (15.88%)
- PET-CT (19.69%)
- Nuclear medicine (29.75%)
In recent papers he was focusing on the following fields of study:
Johannes Czernin mostly deals with Prostate cancer, PET-CT, Nuclear medicine, Radiology and Internal medicine.
His biological study spans a wide range of topics, including Positron emission tomography, Cancer research and Prospective cohort study.
His Positron emission tomography research is multidisciplinary, incorporating perspectives in Glutamate carboxypeptidase II and Psma pet.
His study brings together the fields of Biodistribution and Nuclear medicine.
His Radiology study combines topics in areas such as Androgen deprivation therapy, Randomized controlled trial, Management of prostate cancer and Histopathology.
His biological study deals with issues like Oncology, which deal with fields such as Castrate-resistant prostate cancer, Phases of clinical research and Cancer.
Between 2017 and 2021, his most popular works were:
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial (154 citations)
- 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning (126 citations)
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. (123 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Johannes Czernin focuses on Prostate cancer, PET-CT, Radiology, Nuclear medicine and Biochemical recurrence.
His Prostate cancer study is associated with Internal medicine.
His PET-CT research incorporates elements of Urology, Molecular imaging, Repeatability, Cardiac imaging and Prospective cohort study.
Johannes Czernin combines subjects such as Positron emission tomography, Prior Primary, Glutamate carboxypeptidase II and Disease with his study of Urology.
Johannes Czernin interconnects Esophagectomy, Esophageal cancer, 68Ga-PSMA-11 and Histopathology in the investigation of issues within Radiology.
His research in Nuclear medicine is mostly concerned with Dosimetry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
